Insider · CIK 0001381980
Nina S Kjellson
director
Files at TYRA (Tyra Biosciences, Inc.). First filing Nov 1, 2024, latest Feb 7, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $4.4M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TYRA: Tyra Biosciences, Inc.
TYRAOct 9, 2026 · close 19.94
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | TYRAsell Tyra Biosciences, Inc. | $74k 5,401 shares | -0% | - | |
| 24Weak | TYRAsell Tyra Biosciences, Inc. | $78k 4,825 shares | -0% | - | |
| 31Weak | TYRAsell Tyra Biosciences, Inc. | $410k 25,041 shares | -1% | - | |
| 24Weak | TYRAsell Tyra Biosciences, Inc. | $89k 5,272 shares | -0% | - | |
| 40Moderate | TYRAsell Tyra Biosciences, Inc. | $1.3M 74,582 shares | -2% | - | |
| 27Weak | TYRAsell Tyra Biosciences, Inc. | $194k 11,569 shares | -0% | - | |
| 48Moderate | Tyra Biosciences, Inc. | $2.3M 138,711 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P | -1,890 | $13.76 | $26k | 3,700,705 | Feb 7, 2025 |
| Feb 5, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -3,511 | $13.76 | $48k | 443,885 | Feb 7, 2025 |
| Jan 23, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P | -4,825 | $16.26 | $78k | 3,702,595 | Jan 27, 2025 |
| Jan 16, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -6,944 | $16.29 | $113k | 3,724,221 | Jan 21, 2025 |
| Jan 16, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -835 | $16.29 | $14k | 447,857 | Jan 21, 2025 |
| Jan 17, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -12,808 | $16.40 | $210k | 3,711,413 | Jan 21, 2025 |
| Jan 17, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -461 | $16.40 | $7,560 | 447,396 | Jan 21, 2025 |
| Jan 21, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P | -3,993 | $16.36 | $65k | 3,707,420 | Jan 21, 2025 |
| Nov 25, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -4,706 | $16.84 | $79k | 3,731,165 | Nov 26, 2024 |
| Nov 25, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -566 | $16.84 | $9,531 | 448,692 | Nov 26, 2024 |
| Nov 6, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -46,856 | $17.18 | $805k | 3,755,591 | Nov 8, 2024 |
| Nov 6, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -5,635 | $17.18 | $97k | 451,629 | Nov 8, 2024 |
| Nov 7, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -19,720 | $17.32 | $342k | 3,735,871 | Nov 8, 2024 |
| Nov 7, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -2,371 | $17.32 | $41k | 449,258 | Nov 8, 2024 |
| Nov 4, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -960 | $17.01 | $16k | 3,811,814 | Nov 6, 2024 |
| Nov 4, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -116 | $17.01 | $1,973 | 458,390 | Nov 6, 2024 |
| Nov 5, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -9,367 | $16.77 | $157k | 3,802,447 | Nov 6, 2024 |
| Nov 5, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -1,126 | $16.77 | $19k | 457,264 | Nov 6, 2024 |
| Oct 30, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -9,889 | $16.17 | $160k | 3,926,706 | Nov 1, 2024 |
| Oct 30, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -1,189 | $16.17 | $19k | 472,207 | Nov 1, 2024 |
| Oct 31, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -89,390 | $16.46 | $1.5M | 3,837,316 | Nov 1, 2024 |
| Oct 31, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -10,750 | $16.46 | $177k | 461,457 | Nov 1, 2024 |
| Nov 1, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -23,938 | $16.54 | $396k | 3,813,378 | Nov 1, 2024 |
| Nov 1, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Commmon Stockindirect: By Canaan XI L.P. | -604 | $17.16 | $10k | 3,812,774 | Nov 1, 2024 |
| Nov 1, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -2,878 | $16.54 | $48k | 458,579 | Nov 1, 2024 |
| Nov 1, 2024 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -73 | $17.16 | $1,253 | 458,506 | Nov 1, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.